Since the AOM/DSS treatment associated with an increased number of neoplastic lesions in Emilin-2−/− mice, we hypothesized that the lack of EMILIN-2 could lead to poor tumor immunosurveillance, leading to the escape of a higher number of transformed cells. This evidence concerns the gene EMILIN2 and infectious otitis media.